PERMEON BIOLOGICS, INC. — Form D
PERMEON BIOLOGICS, INC. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-12-08. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-12-08
- Form: D
- Accession: 0001507236-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.5M
- Amount sold: $3.5M
- Investors: 2
- Date of first sale: 2010-11-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-151570
Issuer
- Name: PERMEON BIOLOGICS, INC.
- CIK: 0001507236
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: 617-945-7780
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Noubar L Afeyan, Ph.D. | Director | Cambridge, MA |
| Douglas Cole, M.D. | Director | Cambridge, MA |
| Alex Franzusoff | Executive Officer | Cambridge, MA |
| Keith L Crandell | Director | WOBURN, MA |
| John Edwards | Director | Atlanta, GA |
| John Edwards | Executive Officer | Atlanta, GA |
| Douglas G Cole, M.D. | Director | Cambridge, MA |
| Noubar G Afeyan, Ph.D. | Director | Cambridge, MA |
Other filings by this issuer (1)
More